Growth hormone treatment of short children born small for gestational age or with Silver-Russell syndrome: Results from KIGS (Kabi International Growth Study), including the first report on final height

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 85, Issue 417, 1996, Pages 18-26

  Ranke, M B ^a   Lindberg, A ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Statistics   (Sweden)

Author keywords

catch up growth; final height; growth hormone treatment; height; height prediction; short for gestational age; Silver Russell syndrome

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT PROTEIN;

BODY HEIGHT; CATCH UP GROWTH; CHILD; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHORT STATURE; SILVER RUSSELL SYNDROME; ADOLESCENT; ARTICLE; BIRTH WEIGHT; DRUG EFFECT; DWARFISM; MULTIPLE MALFORMATION SYNDROME; NEWBORN; PHYSIOLOGY; PRESCHOOL CHILD; SMALL FOR DATE INFANT;

ABNORMALITIES, MULTIPLE; ADOLESCENT; BIRTH WEIGHT; BODY HEIGHT; CHILD; CHILD, PRESCHOOL; DWARFISM; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; RECOMBINANT PROTEINS;

EID: 0030499395     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Davies DP. Growth of 'small-for-dates' babies. Early Hum Dev 1981;5:95-105
2. Fitzhardinge PM, Steven EM. The small-for-date infant. I. Later growth pattern. Pediatrics 1972;49:671-81
3. Albertsson-Wikland K, Wennergren G, Wennergren M, Vilbergsson G, Rosberg S. Longitudinal follow-up of growth in children born small for gestational age. Acta Paediatr 1983;82:438-43
4. Westwood M, Kramer MS, Munz D, Lovett JM, Watter GV. Growth and development of full-term nonasphyxiated small-for-gestational-age newborns: follow-up through adolescence. Pediatrics 1983;71:376-82
5. Job JC, Rolland A. Histoire naturelle des retards de croissance à début intra-utérin. Arch Fr Pediatr 1986;43:301-6
6. Tenovuo A, Kero P, Piekkala P, Korvenranta H, Sillanpäa M, Erkkola R. Growth of 519 small for gestational age infants during the first two years of life. Acta Paediatr Scand 1987;76:636-46
7. Fitzhardinge PM, Inwood S. Long-term growth in small-for-date children. Acta Paediatr Scand Suppl 1989;349:27-33
8. Kitchen WH, Doyle LW, Ford GW, Callahan C. Very low birth weight and growth to age 8 years. I: weight and height. Am J Dis Child 1992;146:40-5
9. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995;38:733-9
10. Hokken-Koelega AC, De Ridder MA, Lemmen RJ, Den Hartog H, De Muinck Keizer-Schrama SM, Drop SL. Children born small for gestational age: do they catch up? Ped Res 1995;38:267-71
11. Ranke MB. The KIGS aetiology classification system. In: Ranke MB, Gunnarsson R, eds. Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J&J Verlag, 1994:51-61
12. Niklasson A, Ericson A, Fryer J, Karlberg J, Lawrence C, Karlberg P. An update of the Swedish Reference Standards for weight, length and head circumference at birth for given gestational age (1977-1981; n = 476,588). Acta Paediatr Scand 1991;80:756-62
13. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children (1965). Arch Dis Child 1966;41:454-71, 613-35
14. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford: Stanford University Press, 1959
15. Tanner JM. Fetus into man. London: Open Books, 1978
16. Weisberg S. Applied linear regression. 2nd edn. Chichester: Wiley, 1985
17. Ranke MB, Lindberg A, Guilbaud A, Cole T. Prediction of the growth response in children with various growth disorders treated with growth hormone: analysis of data from the Kabi International Growth Study. Acta Paediatr Suppl 1993;391:82-8
18. Ranke MB, Lindberg A, Guilbaud A. Prediction of growth response to treatment with growth hormone. In: Ranke MB, Gunnarsson R, eds. Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J&J Verlag, 1994:97-111
19. Wollmann HA, Kirchner T, Enders H, Preece MA, Ranke MB. Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr 1995;154:958-68
20. Ounsted M, Moar V, Scott A. Growth in the first four years: II. Diversity within groups of small-for-dates and large-for-dates babies. Early Hum Dev 1982;7:29-39
21. Gluckman PD. Growth hormone deficiency diagnosed and treated in the first 2 years of life: evidence of the role of growth hormone in human perinatal growth. In: Ranke MB, Gunnarsson R, eds. Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J&J Verlag, 1994:88-96
22. Tanner JM, Whitehouse RH, Hughes PCR, Vince FP. Effect of human growth hormone for one to seven years on growth of 100 children with growth hormone deficiency, low birth weight, inherited smallness, Turner's syndrome and other complaints. Arch Dis Child 1971;46:745-82
23. Grunt JA, Enriquez AR, Daughaday WH, Budd S. Acute and long-term responses to hGH in children with idiopathic small-for-dates dwarfism. J Clin Endocrinol Metab 1972;3:157-67
24. Foley TP, Thompson RG, Shaw M, Baghdassavian A. Growth responses to human growth hormone in patients with intrauterine growth retardation. J Pediatr 1974;84:635-41
25. Lanes R, Plotnick L, Lee PA. Sustained effect of human growth hormone therapy on children with intrauterine growth retardation. Pediatrics 1979;63:731-5
26. Albertsson-Wikland K in collaboration with the Swedish Pediatric Study Group for Growth Hormone Treatment. Growth hormone secretion and growth hormone treatment in children with intrauterine growth retardation. Acta Paediatr Scand Suppl 1989;349:35-41
27. Stanhope R, Preece MA, Hamill G. Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation? Arch Dis Child 1991;66:1180-3
28. Chatelain P, Job JC, Blanchard J, Ducret JP, Olivier M, Sganard L, et al. Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth retarded children. J Clin Endocrinol Metab 1994;78:1454-60
29. de Zegher F, Maes M, Gargosky SE, Heinrichs C, Du Caju MV, Thiry G, et al. High-dose growth hormone treatment of short children born small for gestational age. J Clin Endocrinol Metab 1996;81:1887-92
30. Chatelain P, Nicolino M. Intrauterine growth retardation and Silver-Russell syndrome: demography, auxology and response to growth hormone treatment in the Kabi International Growth Study. In: Ranke MB, Gunnarsson R, editors Progress in growth hormone therapy - 5 years of KIGS. Mannheim: J&J Verlag 1994:230-9
31. Chatelain PG, on behalf of the International Board of the Kabi Pharmacia International Growth Study. Auxology and response to growth hormone treatment of patients with intrauterine growth retardation or Silver-Russell syndrome: analysis of data from the Kabi Pharmacia International Growth Study. Acta Paediatr Suppl 1993;391:79-81
32. Ranke MB, Blank B. Is there an auxological basis for growth promoting therapy with human growth hormone in short children? Acta Paediatr Scand Suppl 1990;367:4-10
33. Wilcox MA, Newcon CS, Johnson IR. Paternal influences on birth weight. Acta Obstet Gynecol Scand 1995;74:15-18
34. Hack M, Merkatz IR, McGrath SK, Jones PK, Fanaroff AA. Catch-up growth in very-low-birth weight infants. Am J Dis Child 1994;138:370-6
35. Rosenfeld RG, Frane J, Attie KM, Brasel JA, Burstein S, Cara JF, et al. Six year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr 1992;121:49-55